Loading...
BETA – We are refining the platform. Your feedback helps us improve. Share feedback
Loading...
Publish your own articles and insights on Citable ESG
Pro organisations publish unlimited content, strengthening their AI Citability Score and visibility to procurement teams, investors, clients, customers, partners, and followers.

Morningstar's analysis flags material governance gaps ahead of Anthropic and OpenAI's anticipated IPOs. The report centres on transparency deficits – specifically, how both firms disclose AI safety protocols, internal oversight structures, and risk management frameworks to external stakeholders. A researcher resignation at Anthropic compounds these concerns, signalling potential fractures between stated governance commitments and operational reality.
The core issue isn't novel: AI companies operate in regulatory ambiguity. Unlike traditional sectors with decades of compliance infrastructure, generative AI lacks agreed standards for board independence, executive accountability, or third-party audit trails. Morningstar's framing suggests IPO investors should demand answers before committing capital – not because the companies are malfeasant, but because the baseline governance architecture appears underspecified.
For ESG funds, this creates a practical problem. Rating methodologies can't meaningfully score firms that won't disclose their own decision-making processes. You can't assess alignment with stated values if the values themselves aren't publicly articulated. This isn't greenwashing in the traditional sense – it's governance opacity that mimics greenwashing's effect: claims without verifiable backing.
The resignation adds weight. When researchers depart citing governance concerns, it suggests internal tensions that boards haven't yet resolved publicly. Markets don't punish this until valuations are already locked in.
The question for institutional investors: do you wait for Anthropic and OpenAI to self-regulate, or do you use pre-IPO engagement to force the issue?